Key facts
- Vitable (Woodlyn)’s last known valuation is $65.0M (Jul 2024).
- It has raised $27.4M; the latest was Later Stage VC in Nov 2025.
- Notable investors include Y Combinator, Western Technology Investment, First Round Capital, Commerce Ventures, SoftBank Group — 29 tracked in total.
- Status: Privately Held (backing).
Leadership
- Ricardo CreightonVice President
- Brendan MullinsChief Revenue Officer
- Joseph KitongaChief Executive Officer & Manager
- Nimish ShuklaExecutive Officer
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Vitable (Woodlyn)
- ·The full record, as it builds
Funding rounds
No funding rounds for Vitable (Woodlyn) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vitable (Woodlyn)
Provider of on-demand urgent care and health coverage services intended to serve as a healthcare safeguard for individuals. The company offers expansive coverage, telemedicine, physicals, lab tests, tuberculosis testing, comprehensive health screenings, general medical exams, urinalysis, and other related services, enabling individuals to procure preventative coverage services, all from the comfort of their homes.
- Sector
- Healthcare
- HQ
- Woodlyn, PA, United States
- Founded
- 2018
- Employees
- 96
- Website
- vitablehealth.com/
- Ownership
- Privately Held (backing)
Vitable (Woodlyn) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vitable (Woodlyn) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vitable (Woodlyn) in its N-PORT filings yet. We sweep new filings monthly.